During the past decade, LKH Hochsteiermark - Leoben, Abt. f. Innere Medizin, Haemato-Onkologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "LKH Hochsteiermark - Leoben, Abt. f. Innere Medizin, Haemato-Onkologie" #1 collaborator was "Assign Data Management and Biostatistics GmbH" with 1 trials as a collaborator, "Bionorica SE" with 1 trials as a collaborator, "Medical University of Graz" with 1 trials as a collaborator, "Medical University of Vienna" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "LKH Hochsteiermark - Leoben, Abt. f. Innere Medizin, Haemato-Onkologie" are "Chemotherapy-induced Nausea and Vomiting" (1 trials), "Newly Diagnosed Multiple Myeloma" (1 trials), "Pancreatic Cancer Metastatic" (1 trials) and "Pancreatic Cancer Non-resectable" (1 trials). Many other conditions were trialed in "LKH Hochsteiermark - Leoben, Abt. f. Innere Medizin, Haemato-Onkologie" in a lesser frequency.

Most popular intervention types in "LKH Hochsteiermark - Leoben, Abt. f. Innere Medizin, Haemato-Onkologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone Oral" (1 trials), "Dronabinol in Oral Dosage Form" (1 trials), "Isatuximab-Irfc 20 MG/ML [Sarclisa]" (1 trials), "Lenalidomide" (1 trials) and "Placebo in Oral Dosage Form" (1 trials). Other intervention names were less common.

The vast majority of trials in "LKH Hochsteiermark - Leoben, Abt. f. Innere Medizin, Haemato-Onkologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "LKH Hochsteiermark - Leoben, Abt. f. Innere Medizin, Haemato-Onkologie". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in LKH Hochsteiermark - Leoben, Abt. f. Innere Medizin, Haemato-Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LKH Hochsteiermark - Leoben, Abt. f. Innere Medizin, Haemato-Onkologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".